More bad news about post-menopausal hormone therapy: a new European study reported that, to take hormones significantly increased risk of ovarian cancer are's women rarely but often deadly.
Findings from the European prospective investigation into cancer and nutrition that some 126,920 post-menopausal women included, were at a Conference of the American Association for cancer research presented this week in Philadelphia.
After nine years follow-up 424 ovarian cancer had diagnostiziert.Sogar after controlling for body mass index, smoking and several other risk factors, the researchers found that women, post-menopausal hormone therapy had 29 percent higher risk of ovarian cancer than women not using hormones.
Women hit, facing an increased risk of 63 percent over estrogen used only hormone therapy, after a hysterectomy, not consumers during the increased risk of ovarian cancer in women, with a combination of estrogen and progestin not statistical significance.
Yet, said study author, Konstantinos k. Tsilidis, a cancer epidemiologist at the University of Oxford's cancer epidemiology in England, it was a clear increase in the risk for current user all hormones, but only if you had used hormones for at least five years.
"" It is important that the message out to women ", said Dr. Tsilidis."This is a very fatal cancer."
The number of women hormone therapy dropped after a large trial funded by the national institutes of health, find that hormones has increased the risks of stroke and blood clots, and that the combination therapy increases the risk of breast cancer and heart attacks. many women still, hormones use to treat menopausal symptoms, although you get the lowest dose for as short a period a time as possible to take.
0 comments:
Post a Comment